脓毒症重症患者低胆固醇血症与死亡率的关联:系统评价与Meta分析
本系统评价与Meta分析纳入18项观察性研究、共1,283例脓毒症重症患者,粗总体死亡率为33.3%。分析显示,最终死亡者入ICU时总胆固醇(17项研究,1,204例;MD=0.52 mmol/L [0.27-0.77 mmol/L];p<0.001;I²=91%)、HDL胆固醇(14项研究,991例;MD=0.08 mmol/L [0.01-0.15 mmol/L];p=0.02;I²=61%)和LDL胆固醇(15项研究,1,017例;MD=0.18 mmol/L [0.04-0.32 mmol/L];p=0.01;I²=71%)显著低于存活者。入ICU时甘油三酯水平与死亡率无关(15项研究,1,070例;MD=0.00 mmol/L [-0.16至0.15 mmol/L];p=-0.95;I²=79%)。作者认为,胆固醇替代治疗对脓毒症患者结局的影响值得研究。
要点
- 脓毒症患者入ICU时总胆固醇较低与死亡相关:17项研究、1,204例,死亡者较存活者MD=0.52 mmol/L(95%CI 0.27-0.77),p<0.001,I²=91%。
- HDL胆固醇较低与死亡相关:14项研究、991例,MD=0.08 mmol/L(95%CI 0.01-0.15),p=0.02,I²=61%。
- LDL胆固醇较低与死亡相关:15项研究、1,017例,MD=0.18 mmol/L(95%CI 0.04-0.32),p=0.01,I²=71%。
- 甘油三酯水平与死亡率无关:15项研究、1,070例,MD=0.00 mmol/L(95%CI -0.16至0.15),p=-0.95,I²=79%。
- 18项观察性研究共1,283例脓毒症重症患者,粗总体死亡率为33.3%。
适用人群与场景
- 纳入所有报告脓毒症重症患者入ICU时胆固醇和甘油三酯水平的观察性研究,共18项研究、1,283例患者。
研究设计与关键结果
- 系统评价与Meta分析纳入18项观察性研究,共1,283例脓毒症重症患者,粗总体死亡率为33.3%。
- 最终死亡者较存活者入ICU时总胆固醇显著降低:17项研究、1,204例,MD=0.52 mmol/L(95%CI 0.27-0.77),p<0.001,I²=91%。
- 最终死亡者较存活者入ICU时HDL胆固醇显著降低:14项研究、991例,MD=0.08 mmol/L(95%CI 0.01-0.15),p=0.02,I²=61%。
- 最终死亡者较存活者入ICU时LDL胆固醇显著降低:15项研究、1,017例,MD=0.18 mmol/L(95%CI 0.04-0.32),p=0.01,I²=71%。
- 入ICU时甘油三酯水平与死亡率无关:15项研究、1,070例,MD=0.00 mmol/L(95%CI -0.16至0.15),p=-0.95,I²=79%。
证据类型、等级与局限
- 证据类型:系统评价与Meta分析,纳入18项观察性研究。
- 异质性:总胆固醇分析I²=91%,HDL胆固醇分析I²=61%,LDL胆固醇分析I²=71%,甘油三酯分析I²=79%。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,胆固醇替代治疗对脓毒症患者结局的影响值得研究,尤其在高危人群中。
- 原文未据此给出推荐。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
UNLABELLED: To ascertain the association between cholesterol and triglyceride levels on ICU admission and mortality in patients with sepsis.
DATA SOURCES: Systematic review and meta-analysis of published studies on PubMed and Embase.
STUDY SELECTION: All observational studies reporting ICU admission cholesterol and triglyceride levels in critically ill patients with sepsis were included. Authors were contacted for further data.
DATA EXTRACTION: Eighteen observational studies were identified, including 1,283 patients with a crude overall mortality of 33.3%. Data were assessed using Revman (Version 5.1, Cochrane Collaboration, Oxford, United Kingdom) and presented as mean difference (MD) with 95% CIs, p values, and I 2 values.
DATA SYNTHESIS: Admission levels of total cholesterol (17 studies, 1,204 patients; MD = 0.52 mmol/L [0.27-0.77 mmol/L]; p < 0.001; I 2 = 91%), high-density lipoprotein (HDL)-cholesterol (14 studies, 991 patients; MD = 0.08 mmol/L [0.01-0.15 mmol/L]; p = 0.02; I 2 = 61%), and low-density lipoprotein (LDL)-cholesterol (15 studies, 1,017 patients; MD = 0.18 mmol/L [0.04-0.32 mmol/L]; p = 0.01; I 2 = 71%) were significantly lower in eventual nonsurvivors compared with survivors. No association was seen between admission triglyceride levels and mortality (15 studies, 1,070 patients; MD = 0.00 mmol/L [-0.16 to 0.15 mmol/L]; p = -0.95; I 2 = 79%).
CONCLUSIONS: Mortality was associated with lower levels of total cholesterol, HDL-cholesterol, and LDL-cholesterol, but not triglyceride levels, in patients admitted to ICU with sepsis. The impact of cholesterol replacement on patient outcomes in sepsis, particularly in at-risk groups, merits investigation.
参考来源
- Hofmaenner DA, Arina P, Kleyman A, et al. Association Between Hypocholesterolemia and Mortality in Critically Ill Patients With Sepsis: A Systematic Review and Meta-Analysis. Crit Care Explor. 2023. PMID: 36751516. doi:10.1097/CCE.0000000000000860
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。